TMO – Thermo Fisher Scientific Inc.
TMO — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
1.19
Margin Of Safety %
-8
Put/Call OI Ratio
1
EPS Next Q Diff
0.93
EPS Last/This Y
1.99
EPS This/Next Y
2.4
Price
500.72
Target Price
595.21
Analyst Recom
1.55
Performance Q
4.35
Upside
-20.1%
Beta
0.86
Ticker: TMO
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-06-02 | TMO | 481.99 | 1.00 | 0.18 | 60184 |
| 2026-06-03 | TMO | 474.06 | 0.98 | 1.20 | 61533 |
| 2026-06-04 | TMO | 482.03 | 0.98 | 4.10 | 61877 |
| 2026-06-05 | TMO | 472.65 | 0.98 | 0.48 | 62187 |
| 2026-06-08 | TMO | 469.72 | 0.96 | 1.33 | 59078 |
| 2026-06-09 | TMO | 493.89 | 0.98 | 2.64 | 60535 |
| 2026-06-10 | TMO | 482.02 | 0.99 | 1.94 | 61812 |
| 2026-06-11 | TMO | 475.75 | 1.00 | 4.60 | 62950 |
| 2026-06-12 | TMO | 469.27 | 1.01 | 3.05 | 64010 |
| 2026-06-15 | TMO | 473.81 | 0.94 | 0.81 | 59979 |
| 2026-06-16 | TMO | 472.68 | 0.93 | 1.10 | 60333 |
| 2026-06-17 | TMO | 461.7 | 0.93 | 9.01 | 60585 |
| 2026-06-18 | TMO | 464.5 | 0.93 | 0.57 | 61412 |
| 2026-06-22 | TMO | 464.24 | 0.98 | 0.63 | 41972 |
| 2026-06-23 | TMO | 469.45 | 0.95 | 0.89 | 44732 |
| 2026-06-24 | TMO | 492.08 | 0.95 | 0.45 | 45702 |
| 2026-06-25 | TMO | 505.92 | 0.94 | 0.30 | 46874 |
| 2026-06-26 | TMO | 513.15 | 0.98 | 0.61 | 46497 |
| 2026-06-29 | TMO | 506.22 | 0.97 | 2.53 | 43514 |
| 2026-06-30 | TMO | 500.84 | 1.00 | 0.77 | 44620 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-06-01 | TMO | 494.00 | 6.7 | -469.1 | 24.86 |
| 2026-06-02 | TMO | 480.48 | 6.7 | -678.8 | 24.86 |
| 2026-06-03 | TMO | 473.91 | 6.7 | -606.5 | 24.86 |
| 2026-06-04 | TMO | 482.15 | 6.7 | -370.5 | 24.86 |
| 2026-06-05 | TMO | 472.65 | 6.6 | -623.7 | 24.86 |
| 2026-06-08 | TMO | 469.57 | 6.6 | -536.8 | 24.86 |
| 2026-06-09 | TMO | 494.14 | 6.6 | -133.1 | 24.86 |
| 2026-06-10 | TMO | 482.04 | 6.6 | -658.0 | 24.86 |
| 2026-06-11 | TMO | 475.69 | 6.6 | -580.5 | 24.86 |
| 2026-06-12 | TMO | 469.38 | 6.6 | -580.6 | 24.86 |
| 2026-06-15 | TMO | 473.86 | 6.6 | -424.1 | 24.86 |
| 2026-06-16 | TMO | 472.61 | 6.6 | -506.1 | 24.86 |
| 2026-06-17 | TMO | 461.62 | 6.6 | -649.4 | 24.86 |
| 2026-06-18 | TMO | 464.76 | 6.6 | -444.7 | 24.86 |
| 2026-06-22 | TMO | 464.02 | 6.6 | -498.7 | 24.86 |
| 2026-06-23 | TMO | 469.35 | 6.6 | -411.5 | 24.86 |
| 2026-06-24 | TMO | 492.05 | 6.6 | -159.3 | 24.86 |
| 2026-06-25 | TMO | 505.60 | 6.6 | -301.9 | 24.86 |
| 2026-06-26 | TMO | 513.25 | 6.6 | -387.2 | 24.86 |
| 2026-06-29 | TMO | 506.26 | 6.6 | -581.7 | 24.86 |
| 2026-06-30 | TMO | 500.72 | 6.6 | -568.0 | 24.86 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-06-02 | TMO | -12.77 | -2.48 | 1.29 |
| 2026-06-03 | TMO | -12.77 | -2.48 | 1.29 |
| 2026-06-04 | TMO | -11.40 | -2.48 | 1.29 |
| 2026-06-05 | TMO | -4.70 | -2.48 | 1.29 |
| 2026-06-08 | TMO | -1.81 | -2.56 | 1.29 |
| 2026-06-09 | TMO | -1.81 | -2.56 | 1.29 |
| 2026-06-10 | TMO | -1.81 | -2.56 | 1.27 |
| 2026-06-11 | TMO | -1.81 | -2.56 | 1.27 |
| 2026-06-12 | TMO | -1.81 | -2.56 | 1.27 |
| 2026-06-15 | TMO | -1.81 | -2.56 | 1.27 |
| 2026-06-16 | TMO | -1.81 | -2.56 | 1.27 |
| 2026-06-17 | TMO | -1.81 | -2.56 | 1.27 |
| 2026-06-18 | TMO | -1.81 | -2.56 | 1.27 |
| 2026-06-22 | TMO | -1.81 | -2.59 | 1.27 |
| 2026-06-23 | TMO | -1.61 | -2.59 | 1.27 |
| 2026-06-24 | TMO | -1.50 | -2.59 | 1.27 |
| 2026-06-25 | TMO | -1.50 | -2.59 | 1.27 |
| 2026-06-26 | TMO | -1.50 | -2.59 | 1.19 |
| 2026-06-29 | TMO | -1.81 | -2.59 | 1.19 |
| 2026-06-30 | TMO | -1.81 | -2.59 | 1.19 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
5.44
Avg. EPS Est. Current Quarter
5.71
Avg. EPS Est. Next Quarter
6.37
Insider Transactions
-1.81
Institutional Transactions
-2.59
Beta
0.86
Average Sales Estimate Current Quarter
11701
Average Sales Estimate Next Quarter
11962
Fair Value
463.08
Quality Score
80
Growth Score
74
Sentiment Score
97
Actual DrawDown %
25.5
Max Drawdown 5-Year %
-41
Target Price
595.21
P/E
27.54
Forward P/E
18.42
PEG
1.94
P/S
4.12
P/B
3.58
P/Free Cash Flow
27.59
EPS
18.19
Average EPS Est. Cur. Y
24.86
EPS Next Y. (Est.)
27.25
Target Price Estimates Raised
Target Price Estimates Lowered
1
Profit Margin
15.15
Relative Volume
1.05
Return on Equity vs Sector %
-14.6
Return on Equity vs Industry %
2.3
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.01
EBIT Estimation
-568
◆
TMO
Healthcare
$500.91
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
59.3
Range 1M
80%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
8.7%
EPS NY
9.4%
52W%
41.9%
Long-Term Value
Quality companies, undervalued
WEAK
🟡 HOLD
+11.3% upside
Upside
+11.3%
Quality
80
MoS
-8%
TMO — P/E HistoricalDiagnostics & Research
Thermo Fisher Scientific IncSector: Healthcare
Industry: Diagnostics & Research
Employees: 125000
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It has strategic collaboration with genedrive plc to develop a CYP2C19 pharmacogenetic in vitro diagnostic test. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
TMO
Latest News
—
Caricamento notizie per TMO…
stock quote shares TMO – Thermo Fisher Scientific Inc. Stock Price stock today
news today TMO – Thermo Fisher Scientific Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch TMO – Thermo Fisher Scientific Inc. yahoo finance google finance
stock history TMO – Thermo Fisher Scientific Inc. invest stock market
stock prices TMO premarket after hours
ticker TMO fair value insiders trading